Michael Bigham, Chairman and CEO at Paratek Pharmaceuticals, Inc. (PRTK), sold 32,626 shares at $9.82 ($320K) on 2018-10-03, disclosed to the SEC on 2018-10-04.
Open-market sale of $320k PRTK by Chairman and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.82 | 16,313 | $160K | 50.0% |
| 2 | $9.82 | 16,313 | $160K | 50.0% |
| Total | $9.82 avg | 32,626 | $320K | 100% |
| Filing → |
| PRTK | SELL | 2022-12-14 | $164K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $21K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $152K | — | Filing → |